EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Frequency and Timing of Specialized Formula Prescriptions for Children Under 2 Years

Häufigkeit und Zeitpunkt spezialisierter Formula-Verordnungen bei Kindern unter 2 Jahren

Nikita Punjabi iD, Karen Li, Mark Cunningham, Kimberley Foley iD, Frank Moriarty iD, Sonia Saxena iD, Jennifer K Quint iD, Dougal Hargreaves, Robert J Boyle iD

Clinical & Experimental Allergy · 2026-11 · 56 (11) · 1411-1418

DOI: 10.1111/cea.70447 ↗

Auf einen Blick

In einer populationsbasierten Kohortenstudie erhielten 5,7 % der Kinder unter 2 Jahren spezialisierte Formula. Die Verordnungen nahmen zwischen 2009 und 2021 deutlich zu.

Fragestellung

Wie häufig, wann und wie lange wird spezialisierte Formula bei Kindern bis 2 Jahre verordnet?

Methode

Retrospektive populationsbasierte Kohortenstudie mit CPRD-Aurum-Daten zu in Großbritannien geborenen Kindern von 2009 bis 2021; zusätzlich englische nationale Verordnungsdaten für 2022–2025.

Ergebnisse

1.944.323 Kinder eingeschlossen. 111.478 (5,7 %) erhielten spezialisierte Formula; von 1,7 % in 2009 auf 7,9 % in 2021 und geschätzt 9,7 % in 2025. Erstverordnung meist mit 0–2 Monaten.

Schlussfolgerung der Autor:innen

Die gemeinschaftliche Verordnung spezialisierter Formula in England stieg über den Studienzeitraum etwa fünfmal an und könnte im Säuglingsalter zu einer relevanten Aufnahme freier Zucker führen.

Kernaussagen

  • 5,7 % der Kinder erhielten spezialisierte Formula
  • Erstverordnungen meist im Alter von 0–2 Monaten
  • Wiederholte Verordnungen waren häufig und teils lang andauernd

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 07.10.2026. Verfasst von Nikita Punjabi und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Infant Formula, Milk Hypersensitivity. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Imperial Biomedical Research Centre, NIHR Academic Clinical Fellowship.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infants with non‐specific symptoms are sometimes labelled as cow's milk allergic and managed with specialized formula. These products differ from standard infant formula in protein and carbohydrate source, typically containing lower quality protein and free/added sugars such as glucose polymers or sucrose. We evaluated the frequency, timing, duration and estimated volume of specialized formula prescribed to young children.

Methods

We undertook a retrospective population‐based cohort study of children up to age 2 years born between 2009 and 2021 who were registered with a contributing UK general practice, predominantly in England. Community prescribing and demographic data were obtained from the Clinical Practice Research Datalink (CPRD) Aurum, a de‐identified primary care database representing approximately 24% of the population. National prescribing data for England were used to estimate community prescribing rates for 2022–2025.

Results

Of 4,203,276 children born between 2009–2021 in the database, 1,944,323 (46.3%) were registered by age 3 months with complete data to age 2 years and were included. Of these, 111,478 (5.7%) were prescribed specialized formula, rising from 1.7% of children born in 2009 to 7.9% in 2021 and an estimated 9.7% in 2025. Prescriptions were most commonly initiated at age 0–2 months. Multiple prescriptions were documented for 85,370 (76.6%) of these children. Children with multiple amino‐acid formula prescriptions consumed an estimated mean total of 242 L; those with multiple extensively hydrolysed formula prescriptions 203 L; and those with multiple soya formula prescriptions 137 L. Among these children, the median interval between first and last prescription was 257 days for amino‐acid formula, 213 days for extensively hydrolysed formula and 152 days for soya formula.

Conclusions

Community prescribing of specialized formula in England increased approximately five‐fold over the study period, potentially triggering significant free sugars exposure during infancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant FormulaMilk HypersensitivityHumansInfantRetrospective StudiesChild, PreschoolFemaleMaleInfant, NewbornTime FactorsEngland

Autor:innen und Institutionen

  • School of Public Health, Imperial College London, London, UK.
  • School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

ORCID-Profile: Nikita Punjabi, Kimberley Foley, Frank Moriarty, Sonia Saxena, Jennifer K Quint, Robert J Boyle

Förderung

  • NIHR Imperial Biomedical Research Centre
  • NIHR Academic Clinical Fellowship

Zitieren

APA

Punjabi, N., Li, K., Cunningham, M., Foley, K., Moriarty, F., Saxena, S., Quint, J. K., Hargreaves, D., & Boyle, R. J. (2026). Frequency and Timing of Specialized Formula Prescriptions for Children Under 2 Years. Clinical & Experimental Allergy, 56(11), 1411-1418. https://doi.org/10.1111/cea.70447

Vancouver

Punjabi N, Li K, Cunningham M, Foley K, Moriarty F, Saxena S, et al. Frequency and Timing of Specialized Formula Prescriptions for Children Under 2 Years. Clinical & Experimental Allergy. 2026;56(11):1411-1418. doi:10.1111/cea.70447

BibTeX
@article{Punjabi2026,
  author = {Punjabi, Nikita and Li, Karen and Cunningham, Mark and Foley, Kimberley and Moriarty, Frank and Saxena, Sonia and Quint, Jennifer K and Hargreaves, Dougal and Boyle, Robert J},
  title = {Frequency and Timing of Specialized Formula Prescriptions for Children Under 2 Years},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {1411--1418},
  doi = {10.1111/cea.70447}
}
Kostenlos starten →